100 related articles for article (PubMed ID: 17517864)
1. Biofilms protect Mycoplasma pulmonis cells from lytic effects of complement and gramicidin.
Simmons WL; Dybvig K
Infect Immun; 2007 Aug; 75(8):3696-9. PubMed ID: 17517864
[TBL] [Abstract][Full Text] [Related]
2. Mycoplasma polysaccharide protects against complement.
Bolland JR; Simmons WL; Daubenspeck JM; Dybvig K
Microbiology (Reading); 2012 Jul; 158(Pt 7):1867-1873. PubMed ID: 22504437
[TBL] [Abstract][Full Text] [Related]
3. Resistance of Mycoplasma pulmonis to complement lysis is dependent on the number of Vsa tandem repeats: shield hypothesis.
Simmons WL; Denison AM; Dybvig K
Infect Immun; 2004 Dec; 72(12):6846-51. PubMed ID: 15557605
[TBL] [Abstract][Full Text] [Related]
4. A stochastic mechanism for biofilm formation by Mycoplasma pulmonis.
Simmons WL; Bolland JR; Daubenspeck JM; Dybvig K
J Bacteriol; 2007 Mar; 189(5):1905-13. PubMed ID: 17142389
[TBL] [Abstract][Full Text] [Related]
5. Mycoplasma pulmonis Vsa proteins and polysaccharide modulate adherence to pulmonary epithelial cells.
Bolland JR; Dybvig K
FEMS Microbiol Lett; 2012 Jun; 331(1):25-30. PubMed ID: 22428866
[TBL] [Abstract][Full Text] [Related]
6. The Vsa proteins modulate susceptibility of Mycoplasma pulmonis to complement killing, hemadsorption, and adherence to polystyrene.
Simmons WL; Dybvig K
Infect Immun; 2003 Oct; 71(10):5733-8. PubMed ID: 14500494
[TBL] [Abstract][Full Text] [Related]
7. The Vsa shield of Mycoplasma pulmonis is antiphagocytic.
Shaw BM; Simmons WL; Dybvig K
Infect Immun; 2012 Feb; 80(2):704-9. PubMed ID: 22083715
[TBL] [Abstract][Full Text] [Related]
8. Avoidance of the host immune system through phase variation in Mycoplasma pulmonis.
Denison AM; Clapper B; Dybvig K
Infect Immun; 2005 Apr; 73(4):2033-9. PubMed ID: 15784544
[TBL] [Abstract][Full Text] [Related]
9. Resistance to antimicrobial peptides and stress response in Mycoplasma pulmonis.
Fehri LF; Sirand-Pugnet P; Gourgues G; Jan G; Wróblewski H; Blanchard A
Antimicrob Agents Chemother; 2005 Oct; 49(10):4154-65. PubMed ID: 16189093
[TBL] [Abstract][Full Text] [Related]
10. EPS-I polysaccharide protects Mycoplasma pulmonis from phagocytosis.
Shaw BM; Daubenspeck JM; Simmons WL; Dybvig K
FEMS Microbiol Lett; 2013 Jan; 338(2):155-60. PubMed ID: 23190331
[TBL] [Abstract][Full Text] [Related]
11. Mycoplasma biofilms ex vivo and in vivo.
Simmons WL; Dybvig K
FEMS Microbiol Lett; 2009 Jun; 295(1):77-81. PubMed ID: 19473253
[TBL] [Abstract][Full Text] [Related]
12.
Feng M; Schaff AC; Balish MF
Microbiology (Reading); 2020 Jul; 166(7):629-640. PubMed ID: 32421492
[TBL] [Abstract][Full Text] [Related]
13. Interactions between Mycoplasma pulmonis and immune systems in the mealworm beetle, Tenebrio molitor.
Lim S; Yun HK; Kang KM; Lee BL; Won R; Lee IH
Insect Biochem Mol Biol; 2019 Nov; 114():103231. PubMed ID: 31479697
[TBL] [Abstract][Full Text] [Related]
14. Interaction of cationic antimicrobial peptides with Mycoplasma pulmonis.
Park HJ; Kang KM; Dybvig K; Lee BL; Jung YW; Lee IH
FEBS Lett; 2013 Oct; 587(20):3321-6. PubMed ID: 23994526
[TBL] [Abstract][Full Text] [Related]
15. Densely adherent growth mode, rather than extracellular polymer substance matrix build-up ability, contributes to high resistance of Staphylococcus epidermidis biofilms to antibiotics.
Qu Y; Daley AJ; Istivan TS; Rouch DA; Deighton MA
J Antimicrob Chemother; 2010 Jul; 65(7):1405-11. PubMed ID: 20430788
[TBL] [Abstract][Full Text] [Related]
16. Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment.
Verma V; Harjai K; Chhibber S
J Antimicrob Chemother; 2009 Dec; 64(6):1212-8. PubMed ID: 19808232
[TBL] [Abstract][Full Text] [Related]
17. Rat strains differ in susceptibility to maternal and fetal infection with Mycoplasma pulmonis.
Reyes L; Shelton M; Riggs M; Brown MB
Am J Reprod Immunol; 2004 Mar; 51(3):211-9. PubMed ID: 15209390
[TBL] [Abstract][Full Text] [Related]
18. Biofilm formation by mycoplasma species and its role in environmental persistence and survival.
McAuliffe L; Ellis RJ; Miles K; Ayling RD; Nicholas RAJ
Microbiology (Reading); 2006 Apr; 152(Pt 4):913-922. PubMed ID: 16549656
[TBL] [Abstract][Full Text] [Related]
19. Activities of antimicrobial peptides and synergy with enrofloxacin against Mycoplasma pulmonis.
Fassi Fehri L; Wróblewski H; Blanchard A
Antimicrob Agents Chemother; 2007 Feb; 51(2):468-74. PubMed ID: 17101680
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting mild steel corrosion from sulfate-reducing and iron-oxidizing bacteria using gramicidin-S-producing biofilms.
Zuo R; Wood TK
Appl Microbiol Biotechnol; 2004 Nov; 65(6):747-53. PubMed ID: 15278311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
